As of May 21
| -0.04 / -0.94%|
The 4 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 6.25, with a high estimate of 9.00 and a low estimate of 4.00. The median estimate represents a +48.81% increase from the last price of 4.20.
The current consensus among 8 polled investment analysts is to Hold stock in Arena Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.